Coronary artery calcification found on CT predicts death
Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Visual assessment of coronary artery calcification on low-dose CT scans provides a significant indicator of cardiovascular death, a study found.
Coronary artery calcification was assessed on ungated low-dose CT scans of the chest in a cohort of 8782 smokers aged 40 to 85. Each participant received a coronary artery calcification score of 0 to 12. The date and cause of death were obtained through the National Death Index.
The rate of cardiovascular deaths increased with an increasing coronary artery score. For patients with a score of zero, the rate was 1.2%. For patients with a score of one to three, the rate was 1.8%; for patients with a score of seven to 12, the rate was 5.3%. A score of at least four was a significant predictor of cardiovascular death, the researchers said. Follow-up ranged from 0.3 months to 91.9 months with a median of 72.3 months (Radiol 2010;257:541-548).
Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.Even after adjusting for sex, age, and pack-years of smoking, the coronary artery calcification score remained significant.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
